A detailed history of Avantax Advisory Services, Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 9,077 shares of BLFS stock, worth $195,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,077
Previous 7,827 15.97%
Holding current value
$195,155
Previous $203,000 1.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025

BUY
$22.84 - $28.49 $28,550 - $35,612
1,250 Added 15.97%
9,077 $207,000
Q4 2024

Feb 07, 2025

SELL
$20.47 - $27.47 $25,628 - $34,392
-1,252 Reduced 13.79%
7,827 $203,000
Q3 2024

Nov 13, 2024

BUY
$19.19 - $26.52 $174,226 - $240,775
9,079 New
9,079 $227,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $918M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.